The groundbreaking treatment of this peptide represents a exciting breakthrough in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone https://tirzepatidepeptide035906.tusblogos.com/42701286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment